Most Recent
Andrew Hopkins has resigned from his position as group CEO of automotive repair firm AMA and has discontinued his lawsuit against the company despite a Federal Court injunction barring his dismissal amid allegations of fraud.
A judge has rejected a judicial review request by One Nation chief-of-staff James Ashby who sought to have the Commonwealth foot the bill for nearly $4.5 million in legal costs stemming from a dropped sexual harassment case against former House speaker Peter Slipper.
Concerns behind criticism that courts aren't equipped to assess a class action funder's commission are exaggerated, and the fixing by judges of reasonable remuneration, at least in other cases, is nothing new, a Federal Court judge has said.
A judge has ordered the winding up of M101 Nominees, the issuer of $67 million in notes promoted by James Mawhinney's failed Mayfair 101, which is alleged to owe investors over $211 million.
A $100 million shareholder class action against supermarket giant Woolworths has settled for $44.5 million, a few days before a 15-day trial was set to begin.
Automotive firm AMA Group will seek to discharge an injunction preventing it from dismissing a CEO who has been accused of defrauding the company of "hundreds of thousands of dollars" and damaging its reputation with major partners.
A judge has hit a Port Melbourne container terminal with costs for wasting time in a $80 million lawsuit against the CFMEU over picketing at the world's first fully automated container terminal, finding the company's explanations for the delay, including that COVID-19 had slowed it down, were "inconsistent" and "odd".
Google is looming large over the advertising technology world, the ACCC says in a new report highlighting growing concerns the global tech giant's "unrivalled" ability to preference its own technology could affect competition.
A lawsuit seeking to increase D&O insurance for sandalwood producer Quintis in the wake of a class action settlement has fallen short of the $40 million in additional coverage sought, but a Federal Court decision may see a further $11.25 million go to group members.
Multinational pharmaceutical company Dr Reddy's has launched a lawsuit against a Melbourne biotechnology company's directors as well as venture capital firm OneVentures, alleging they sold it dodgy lice treatment which was forecasted to make over US$100 million.